MXPA04001526A - Composiciones de polipetidos kgf. - Google Patents

Composiciones de polipetidos kgf.

Info

Publication number
MXPA04001526A
MXPA04001526A MXPA04001526A MXPA04001526A MXPA04001526A MX PA04001526 A MXPA04001526 A MX PA04001526A MX PA04001526 A MXPA04001526 A MX PA04001526A MX PA04001526 A MXPA04001526 A MX PA04001526A MX PA04001526 A MXPA04001526 A MX PA04001526A
Authority
MX
Mexico
Prior art keywords
kgf
polypeptides
polypeptide compositions
compositions
kgf polypeptide
Prior art date
Application number
MXPA04001526A
Other languages
English (en)
Spanish (es)
Inventor
J Gospodarowicz Denis
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23217561&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MXPA04001526(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiron Corp filed Critical Chiron Corp
Publication of MXPA04001526A publication Critical patent/MXPA04001526A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
MXPA04001526A 2001-08-21 2002-08-21 Composiciones de polipetidos kgf. MXPA04001526A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31388101P 2001-08-21 2001-08-21
PCT/US2002/026929 WO2003016505A2 (en) 2001-08-21 2002-08-21 Kgf polypeptide compositions

Publications (1)

Publication Number Publication Date
MXPA04001526A true MXPA04001526A (es) 2004-05-31

Family

ID=23217561

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04001526A MXPA04001526A (es) 2001-08-21 2002-08-21 Composiciones de polipetidos kgf.

Country Status (8)

Country Link
US (2) US7265089B2 (https=)
EP (1) EP1429799A4 (https=)
JP (2) JP2005500390A (https=)
AU (1) AU2002326742B2 (https=)
CA (1) CA2457781A1 (https=)
MX (1) MXPA04001526A (https=)
PL (1) PL374269A1 (https=)
WO (1) WO2003016505A2 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011008904A1 (en) 2009-07-17 2011-01-20 Tabor Aaron T Compositions and methods for genetic modification of cells having cosmetic function to enhance cosmetic appearance
RU2016117275A (ru) 2013-11-01 2017-12-04 Сфериум Биомед С.Л. Тельца включения для трансдермальной доставки терапевтических и косметических средств
TW201613622A (en) * 2014-10-14 2016-04-16 Bionet Corp Composition for skincare and pharmaceutical composition and preparation method thereof
CN109402130A (zh) * 2018-11-23 2019-03-01 成都中医药大学附属医院 一种重组人角质细胞生长因子-1及其制备方法和用途
KR20230127721A (ko) * 2022-02-25 2023-09-01 한국해양과학기술원 온도안정성을 향상시킨 fgf7 폴리펩타이드 및 그 용도

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2250213C2 (ru) 1989-01-31 2005-04-20 Джеффри С. РУБИН Выделенный белок фактора роста кератиноцита (kgf), рекомбинантная молекула днк, вектор, способ конструирования клетки-хозяина, способ получения белка, фармацевтическая композиция
US5194596A (en) 1989-07-27 1993-03-16 California Biotechnology Inc. Production of vascular endothelial cell growth factor
US5350836A (en) 1989-10-12 1994-09-27 Ohio University Growth hormone antagonists
US5655870A (en) * 1993-03-01 1997-08-12 Kawasaki Steel Corporation Stacker crane in a warehouse
US5814605A (en) 1993-03-26 1998-09-29 Amgen Inc. Therapeutic uses of keratinocyte growth factor
CA2166278A1 (en) * 1993-06-29 1995-01-12 Denis J. Gospodarowicz A truncated keratinocyte growth factor (kgf) having increased biological activity
SI0785950T1 (en) 1994-10-13 2003-08-31 Amgen Inc. Keratinocyte growth factor analogs
SI0785949T1 (en) * 1994-10-13 2003-08-31 Amgen Inc. Method for purifying keratinocyte growth factors
WO1996011949A2 (en) * 1994-10-13 1996-04-25 Amgen Inc. Analogs of keratinocyte growth factor
US5841605A (en) * 1996-11-06 1998-11-24 Iomega Corporation Caddy for cartridge and disk drive accomodating a caddy
EP1012186B1 (en) 1996-12-06 2002-07-17 Amgen Inc., Use of a kgf protein product(s) and a glp-2 protein product(s) for the preparation of a medicament

Also Published As

Publication number Publication date
US20030109439A1 (en) 2003-06-12
WO2003016505A3 (en) 2004-01-08
JP2009221207A (ja) 2009-10-01
WO2003016505A2 (en) 2003-02-27
EP1429799A2 (en) 2004-06-23
JP2005500390A (ja) 2005-01-06
US20080200378A1 (en) 2008-08-21
AU2002326742B2 (en) 2007-05-31
PL374269A1 (en) 2005-10-03
US7265089B2 (en) 2007-09-04
EP1429799A4 (en) 2005-12-21
CA2457781A1 (en) 2003-02-27

Similar Documents

Publication Publication Date Title
ATE293159T1 (de) Stabilisierendes verdünnungsmittel für polypeptide und antigene
WO2002020767A3 (en) G-csf analog compositions and methods
WO2002085923A3 (en) In vivo incorporation of unnatural amino acids
EP2279754A3 (en) Remodelling and glycoconjugation of human growth hormone (hGH)
YU9404A (sh) Multimerna, usmerena kontrastna sredstva na bazi peptida
IL142350A0 (en) Interferon-beta fusion proteins and pharmaceutical compositions containing the same
MY137181A (en) Pulmonary administration of chemically modified insulin
WO1998033509A3 (en) Useful properties of human lactoferrin and variants thereof
DE69823046D1 (de) Praktische in vitro sialylierung von rekombinanten glykpproteinen
WO2003010288A3 (en) Yeast expression systems, methods of producing polypeptides in yeast, and compositions relating to same
MXPA02004666A (es) Gelatinas recombinantes.
EP1686172A3 (en) Myocardial grafts and cellular compositions useful for same
WO1999045098A3 (en) Delivery or proteins into eukaryotic cells with recombinant yersinia
TWI317736B (en) Methods for the production of redox proteins and heteromultimeric-protein-complexes, and related compositions related applications
AU2002310321A8 (en) Compositions and methods for high-level, large-scale production of recombinant proteins
AU2002232819A1 (en) Methods for the production of multimeric proteins, and related compositions
WO1997020933A3 (en) Mutational variants of mammalian ob gene proteins
MXPA03010684A (es) Peptidos y el uso de los mismos para oscurecer la piel.
WO2003031598A3 (en) Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use
BR0312889A (pt) Polipeptìdeo t20 peguilado
MXPA04001252A (es) Nuevos heterociclos benzo-fusionados como antagonistas de endotelina.
MXPA04001526A (es) Composiciones de polipetidos kgf.
MXPA03010683A (es) Composicion que contiene un peptido y un pigmento y el uso del mismo para oscurecer la piel.
AU2002365269A8 (en) Mut-il-18 or mut-il-18r proteins, antibodies, compositions, methods and uses
AU2003251729A1 (en) Use of antibodies against flt-1 for the treatment of osteoporosis

Legal Events

Date Code Title Description
HC Change of company name or juridical status
FG Grant or registration